Invention Grant
US08168820B2 Deuterated catecholamine derivatives and medicaments comprising said compounds
有权
氘代儿茶酚胺衍生物和包含所述化合物的药物
- Patent Title: Deuterated catecholamine derivatives and medicaments comprising said compounds
- Patent Title (中): 氘代儿茶酚胺衍生物和包含所述化合物的药物
-
Application No.: US10539845Application Date: 2003-12-18
-
Publication No.: US08168820B2Publication Date: 2012-05-01
- Inventor: Rudolf-Giesbert Alken
- Applicant: Rudolf-Giesbert Alken
- Applicant Address: DE Neuenhagen
- Assignee: BDD Berolina Drug Development GmbH
- Current Assignee: BDD Berolina Drug Development GmbH
- Current Assignee Address: DE Neuenhagen
- Agency: Davidson, Davidson & Kappel, LLC
- Priority: DE10261807 20021219
- International Application: PCT/DE03/04203 WO 20031218
- International Announcement: WO2004/056724 WO 20040708
- Main IPC: C07B59/00
- IPC: C07B59/00 ; C07C229/08 ; A61P25/00 ; A61K31/198
Abstract:
The present invention concerns deuterated catecholamine derivatives as well as pharmaceuticals containing these compounds. In addition, the invention concerns the use of deuterated catecholamine derivatives as well as physiologically compatible salts thereof, and also pharmaceutical compositions, which contain these compounds, also in combination with enzyme inhibitors, for the treatment of dopamine deficiency diseases or diseases which are based on disrupted tyrosine transport or disrupted tyrosine decarboxylase, as well as other disorders.
Public/Granted literature
- US20060135615A1 Deuterated catecholamine derivatives and medicaments comprising said compounds Public/Granted day:2006-06-22
Information query
